glp-1 landscape The Medicine Maker Pharma Competitive Intelligence in One

PMID: 37276988

1 The arrival of glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes, has reshaped the treatment landscape

Metformin Metformin is a drug widely prescribed in psychiatric patients diagnosed with T2DM, but rarely in a preventive manner, even though several studies found this drug to be efficient in preventing both obesity and T2DM ( Metformin was demonstrated to result in 2.935 kg weight loss after 6 months of treatment even when prescribed after the onset of metabolic dysregulation ( Glucagon-Like Peptide-1 (GLP-1) Recently, there has been a strong interest in the GLP-1 agonists, including liraglutide (Victoza), exenatide (Byetta), and albiglutide (Tanzeum)

[DOI] [PubMed] [Google Scholar] 550.Kapodistria K., Tsilibary E.P., Kotsopoulou E., Moustardas P., Kitsiou P

Magnesium citrate is one of the most commonly used forms, offering good bioavailability and relatively high absorption rates

doi: 10.3390/ijms25084300